Women Empowerment – Barriers & Blocks!

Many women are not ambitious enough when compared to their male counter-parts, especially in the eyes of business owners, CEOs and Boards who have to take the decision to promote them to the top. They give up the race too soon and take a step back.  They are afraid to openly profess their ambition.  They, on their own, attach expiry dates to their career (I’ll focus on my career until…I get married, have my baby, overseas posting, become Vice-President etc) and thus suffer from a “best before” syndrome.  They often end up focusing their mind and emotions on reconciling themselves to what is “not meant for me” instead of setting themselves higher and stretch goals to work towards.

2.  Most women don’t negotiate hard enough for financial rewards and benefits when compared to their male counter-parts. They very easily settle for less than men in terms of pay and rewards.  This can also undermine their perceived ‘toughness’ and suitability for Senior Corporate positions.

3.  Women tend to underplay themselves in success situations, giving away a lot of credit to the team and others whereas men exaggerate their capabilities and achievements. A habit of under-playing leads them to underestimate their own capabilities vs. men who very easily begin to believe that they are “awesome”.  This underplaying can cost women big jumps and challenging assignments when they are compared with a male candidate for the same position / assignment.

4. They don’t have sufficient clarity on what motivates them to seek senior leadership positions and the rewards and fulfillment they experience from the same. Senior leadership positions are high pressure positions by definition and they have many negatives and issues to deal with.  Possessing sufficient self-awareness to know what the personal highs are, that makes the lows worthwhile is important in order to hold on to and succeed in leadership positions.

5.  Women, in India especially, give away their authority and power to men. They are raised and conditioned to ‘seek permission’ instead of taking their own decisions and standing by them.  Hence, they are always trying to second guess the preference of those in authority/wield the power and satisfy them rather than making up their own mind and persuading others of the worth of their own point-of-view.

6. Successful women with leadership potential often have multi-faceted personalities and a wider range of interests. They are often framing their life story as a personal choice exercised between personal fulfillment as professional success vis-a-vis rising to the top of their field as professional success.  This can lead them into interesting explorations, no doubt, but can cause them to vacate their potentially available slots in positions of power and authority in Corporate India.

Societal & Cultural Barriers that create and strengthen these internal barriers are:

1. The cultural codes/rules of India require women to take on home and family responsibilities and deliver on them to an excellent standard. These include FOOD, laundry and home management as well as raising champion children.  This is the traditional role assigned by Society to women and Society at large is not willing to re-negotiate these role expectations from women.  Hence, women end up having to work two and three shifts or be expert jugglers for decades and learn to manage their guilt around not meeting up to societal standards in their traditional role.

2.  From the “beta-beti” syndrome, it is clear that Indian society is more comfortable with the notion of empowering women to reach equal status with men, albeit raised and expected to perform different roles in the family, extended family and society.  Indian society is not yet ready to view men and women as equal individuals with equal rights and seeking equal opportunities for realizing their own potential as people, based upon their own preferences and choices.

Combined Task Force Lightning focus on women and girls health education

3. Men are still raised to be helpless in home management, cooking, laundry etc which are the traditional role domain of women. They therefore are expecting that their wives will partner them to support them to reach the top, rather than vice-versa.  Ambitious women with leadership potential need to choose their partner wisely if they are not to be disadvantaged.

4.  Society is prejudiced against women displaying male qualities of power, aggression, ambition, ruthlessness etc that are required from successful Leaders. The same qualities that are perceived as positives and attractive in a man are viewed negatively, when visible in a woman.  This then leads to positive ‘labels’ being attached to the male leader and negative ‘labels’ being attached to a woman leader.  This social phenomenon places a double bind on ambitious women with leadership potential to reach the top.  Do we become “pseudo-men” or is there a way to stay true to ones “feminine” nature and still reach the top?

5.  To achieve the goal of having many more women leaders on Corporate Boards, professional women need a banner under which to express their ambitions and garner collective support for their effort. Theirs is an argument for equality, earned on merit because merit and capability are gender neutral.  However, the well-known banner for this argument, “Feminism” comes with many negative connotations.  These range from “Western, not Indian” to “bra-burning” hippie women who take to the streets to “male-bashers” who blame men for all women’s ills.  Hence proclaiming oneself as a Feminist does not help the cause.  Senior women in corporate leadership roles today shy away from using the label of Feminist for themselves / Feminism as the banner for their effort.  On the other hand, the alternative banner of Women’s Empowerment is redolent of patriarchy and a patronage relationship, wherein men at the top who have the power are uplifting women with merit and empowering them.  Women who have reached the top on merit want their place as a matter of right not as a matter of patronage.  They also want to build a corporate culture of aspiration and merit not one of patronage and clientilism.

Success mantras / Inspirations for women with leadership ambitions to address and overcome some of these blocks and barriers at an Individual level:

1.  Self-care – women need to focus on their health, their appearance and image and keep themselves fit as well as dress to project themselves as people with authority.

2.  Communication – women need to learn to tell and sell their own story better within their families, communities and organizations in order to enlist support for themselves as well as to further their own ambitions.

3.  Tenacity – women need to learn to stay on track, not lose their drive, ambition and focus and give up too early.

4.  Awareness – women need to identify and learn to eliminate the “noise” of all the subliminal messages from society and culture that subtly undermine them or take them off track.

5.  Asking for support via training/coaching/mentoring – women need to be comfortable with the idea of investing in their own professional growth and development, either via organizational programs or via personal investment. They also need to be willing to give the time and effort required for this type of professional growth.

Starter thoughts for collective effort to build a community of Corporate Women Leaders:

1.  Diversity Programs have been started in the past two to three years in many Corporates with the aim of giving more Board positions to women as well as building a pipeline of potential women leaders over time. At the Board level, these have run into road blocks because Senior Men on the Board are not convinced of the real benefits of Diversity to companies, and more importantly for them, individually.  How do powerful men gain by giving up positions on Boards to women?  As of now there seems to be no persuasive or convincing answer – this is a challenge to be worked upon.

2.  Diversity Programs aimed at middle level pipeline building are effective when they open up a safe space for dialogue between men and women in the workplace.

3.  Women’s Leadership Conferences need to attract more male attendees as well as design spaces and formats for dialogue between Men and Women Leaders.

4.  Mentoring is necessary and each woman leader at her own level needs to adopt and mentor younger women with potential and aspirations

5.  Support groups – there need to be forums and support groups that Women Leaders can turn to during the course of their career journey

Top Cardiologist Dr. Kaushal Pandey honored at Pharma Leaders Super Brand Awards 2015

Top Cardiologist Dr. Kaushal Pandey honored at Pharma Leaders Super Brand Awards 2015

Asia’s Most Valuable & Breakthrough Innovator in Cardio Thoracic  & Vascular Surgery 2015 Award Conferred to Dr. Kaushal Pandey, Cardio Thoracic and Vascular Surgeon

The 8th Annual Pharmaceutical Leadership Summit & Business Leadership Awards was successfully concluded at the financial capital of india in Mumbai at Hotel Hilton today where more than 300 top leaders of the healthcare industry had gathered to be the part of the historic debate on  “Pharma Leaders 2015, Brand India Winning”. Widely acclaimed in the healthcare industry as the pioneer in recognizing the leaders of today & tomorrow, Pharma Leaders brought together veteran healthcare leaders under one platform. The leadership Summit in the afternoon session debated crucial topics such as Healthcare Insurance, Medical Tourism, Challenges of Indian Pharma Industry. Hinduja Hospital CEO Mr. Gautam Khanna debated on the challenges of Indian Healthcare Insurance while Padma Sree Prof Dr. Shashank Joshi addressed on Brand India.

 

 

 

Dr.Kaushal Pandey made a passionate presentation on World Class Individuals : mediocre institutions: & failing medical education. The Award Winning Cardiac Surgeon stressed the need for qualatative improvement of healthcare services in the country to make healthcare accessable to the indian masses.

Expressing concern over the falling standard of education in both public and private medical colleges affecting patient care and healthcare quality in the country, Dr Kaushal Pandey, one of the renowned consultant cardiovascular surgeons associated with P. D. Hinduja National Hospital & Research Center, has stressed on the need for a major overhaul of the medical education system to produce quality doctors to ensure high quality healthcare.

“India produces around 50,000 MBBS doctors annually as compared to 18,000 doctors in USA but training of our doctors are not up to the mark as compared to doctors abroad. In India, the MBBS students do not get enough exposure to clinical materials and surgical procedures during the course to become well trained doctors, and there are a chunk of students who don’t have aptitude to become a doctor but they join a medical college just because their parents manage to secure seats for them in the medical college. Such doctors are risk for patients. The quality of the faculty in medical colleges is also not up to the mark,” said Dr. Pandey.

There is no legal compulsion for doctors to undergo re-training in the country. There is no system to audit the doctors on any quality of care measures which provide them freedom to do whatever they want after the basic qualification is secured. In absence of scrutinisation and monitoring to ensure accountability of doctors in public hospitals in both urban and rural areas, absenteeism among doctors has become common sight leaving scores of needy patients in lurch. It is not the case with private hospitals which have a stringent monitoring system to make doctors accountable to patient care, he said.

“If the government is really worried about people’s health and if the country is to stay competitive globally, it has to exercise its authority to introduce reform to medical entrance test so that students having aptitude to become a doctor get admission to medical colleges. Commercialisation of medical education flooding the market with poor quality doctors should be stopped at the earliest without any loss. The exorbitant capitation fees charged by private medical institutes from students should be regulated to make education affordable for deserving and needy students and steps need to be taken to overhaul the regulatory framework pertaining to quality of instruction, faculty development and curbing private practice,” noted cardiac surgeon said.

In order to overcome the shortage of quality faculty members in public medical colleges, the government needs to revive the old honourary system attached to healthcare in the country where talented, renowned doctors used to conduct classes for students in government medical colleges for two-three days imparting them theoretical and practical insight into the course. They used to charge nominal fees for it, he added.

He said that the government also needs to make integrated protocol-based diagnoses and treatment systems into the teaching programme for medical students and make them take a test after a certain period to ensure their skills updation and encourage use of technology with applications like clinical decision support systems to improve the quality of healthcare delivery.

Geographical location and infrastructure facilities should be taken into account in starting an AIIMS like institutes in the country by the government to ensure maximum optimisation of such facilities, he concluded.

Of the 4,000-odd multi-crore infrastructure projects in the country, only nine (0.21%) – with a total investment of Rs 938 crore – are in the health sector, according to data published by the finance ministry.The public-private partnership (PPP) projects range from diagnostic centres to super-specialty hospitals. Investments in the health sector are far lower than those in the transport and energy sectors. The lack of health facilities in India’s villages reflects the low investment.About 20% (35,389) of the 182,709 public health facilities in rural areas do not have their own premises, according to a 2014 rural health statistics report. There was a shortage of 6,700 (23%) public health centres and 2,350 (33%) community health centres as of March 31, 2014, according to data tabled in the Rajya Sabha.Government spending on health has come down from Rs 37,000 crore ($5.5 billion) in 2013-14 to Rs 30,000 crore ($4.5 billion) in 2014-15. India spent $69 per capita on health in 2013, the lowest among developing nations. Even poorer economies like Indonesia and Mexico did better, according to data published by the Organization for Economic Co-operation and Development


Dr.Kaushal Pandey received the prestigious award title “Asia’s Most Valuable & Breakthrough Innovator in Cardio Thoracic  & Vascular Surgery 2015from the hands of the iconic music composer Louis Banks who has often  been referred to as the Godfather of Indian Jazz  in the presence of Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders Group.

Dr.Kaushal Pandey is one of country’s top cardiologist & is much respected & admired in the healthcare profession.Dr.Kaushal Pandey specializes in Cardiovascular & Thoracic Surgery & his area of Interest are in Bilateral IMA and Radial Artery Grafts for CABG, LV Aneurysm and CABG in poor L V function,Bio Prosthetic Valve Replacement,Redo Valve and Redo CABG Surgery,Infective Endocarditis and infections in Cardiac Surgery & his Key Achievements include among many are winning  P. K. Sen Memorial Oration award at Indian Association of Cardiovascular thoracic Surgeons Conference, 2006, Dr. K. N. Dastur Memorial Oration award at IACTS CON 2012. Dr.Kaushal Pandey is credited with performing of over 14500 open-heart surgery procedures in Mumbai since 1991,Over 50 major presentations and articles in national and international conferences and journals.In the year. Pharma Leaders crowned him as Incredible Medical Expert of the Decade in the year 2013 & Indian Affairs ( A Division of Network 7 Media Group) felicitated the accomplished cardiac surgeon as India’s Most Promising Face in Cardiology at the 3rd Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2015.


Microlab’s CARIPILL receives Emerging Brand of the Year at the 8th Annual Pharmaceutical Leadership Summit & Pharma leaders Business Leadership Awards 2015

Microlab’s CARIPILL receives Emerging Brand of the Year at the 8th Annual Pharmaceutical Leadership Summit & Pharma leaders Business Leadership Awards 2015

The 8th Annual Pharmaceutical Leadership Summit & Business Leadership Awards was successfully concluded at the financial capital of india in Mumbai at Hotel Hilton today where more than 300 top leaders of the healthcare industry had gathered to be the part of the historic debate on  “Pharma Leaders 2015, Brand India Winning”. Widely acclaimed in the healthcare industry as the pioneer in recognising the leaders of today & tomorrow, Pharma Leaders brought together veteran healthcare leaders under one plattform. The leadership Summit in the afternoon session debated crucial topics such as Healthcare Insurance, Medical Tourism, Challenges of Indian Pharma Industry. Microlab’s CARIPILL received the top recognition at the Pharma Leaders Power Brand Awards. Mr. Ashok Jain, Executive Director of Microlabs received the Trophy & Certificate of Excellence from Mr. Louis Banks who has often  been referred to as the Godfather of Indian Jazz & the iconic music composer was the Chief Guest of the evening conferred to top achievers of the country & urged the industry to provide affordable medicines to the common masses in india.

 Satya Brahma, founder of Pharmaleaders in the opening address lambasted the union government for the faulty healthcare reforms & policy paralysis. In a scathing attack to the policy makers, Satya said “the Healthcare Challenges in India at present are of different dimensions & more of cleaning the system at the helm who are responsible for formulating laws, rules & regulations. While we can’t ignore the concerns of the pharma companies facing complex issues in regulatory legal hurdles in IPR challenges, pricing &other issues related to patent regime. Pharmaleaders believe that the evolving global and domestic market dynamics are likely to result in significant opportunities and challenges for pharma companies operating in India, both Indian companies as well as Indian affiliates of MNC companies. Some key issue areas are already starting to capture the attention of leadership teams within the industry.


Bengaluru-based Micro Labs, a fully integrated pharma company recently launched Caripill, which helps to increase the platelet count in patients suffering from dengue.  Approved by the scientific and regulatory authority, the pill is made from Carica Papaya leaf extract and reportedly does not have any side-effects.  Being a product of extensive R&D and clinical trials conducted by Micro Labs, the pill has proved its safety and efficacy in about one lakh patients across India, claims a company release.

MicrolabsCaripill Syrup Pack shotCaripill Tablet Pack shot
Speaking about Caripill, Dr AC Gowda Fortis Hospital, Bangalore and Principal Investigator, Clinical Trial for Caripill said, “The encouraging results on the dengue patients has shown the immense potential of what Caripill is capable of, that eventually can be administered on patients with other life-threatening diseases, like leukaemia among others, which requires intense chemotherapy leading to loss of platelets.” He added, “After an extensive research across two years conducting clinical trials on 250 patients, we have seen positive results with a dramatic decrease in the haemorrhage condition, besides, none of the patients who are administered the drug have had to undergo blood transfusion so far.”

Caripill costs Rs 25 per tablet with the dosage of administering one pill (1100 mg) three times a day, for five days.

No specific treatment was available for treating dengue, except for some paracetamol tablets (mostly Dolo 650 by Micro Labs) to reduce the fever/ temperature. However, immediately post the fever reduces, the platelets count on blood starts falling leading to serious health consequences. Despite considerable efforts to control the mosquito population, dengue fever has emerged, spread and established itself rapidly. Looking into the limited current modalities of treatment and its affordability to a fewer sections of population, Caripill can be of considerable use.

Ashok Jain, Executive Director, Micro Labs, stated, “Over four decades, we have been successful in manufacturing oral solids, liquids, topical and injectable medication for patients across verticals – diabetology, cardiology, ophthalmology, dermatology, pain/analgesics, etc.  Today, I would like to congratulate our team at Micro Labs for making a remarkable breakthrough in treating moderate to severe dengue cases with the newly introduced Caripill that comes at an affordable cost.”

Dr Nagabhushan KH, VP-Medical Services, Micro Labs, stated, “At present, the popular treatment for dengue is by oral consumption of juice crudely extracted from the non-standardised and unhygienic papaya leaves with no clear dosage specified, that could have a detrimental impact on sufferers. Our new Caripill, has received positive feedback from doctors treating patients with dengue and are confident the usage of the pill can be further extended to treating patients with other life-threatening disorders that require restoration of blood platelets.”  He further added, “The rising number of dengue cases among children, has driven us to introduce a paediatric Caripill syrup for easy consumption and plan to launch it soon.”

Caripill has been made available in all major pharmacies across India.

Reportedly it doesn’t have any side effects. According to the clinical trials, Caripill has shown positive results. A plus point is, none of them had to undergo blood transfusion. And henceforth, they are thinking of utilizing in patients with leukemia who have thrombocytopenia post chemotherapy, in future. As far as I have come across, it costs 25/- per tablet. Presently if we see the limited modalities of treatment, and the fact that it can be afforded only by fewer strata of the society, I think yes, Caripill can be worth it. Yes, caripill has some questions before it is fully accepted as platelet booster. However, given the scenario of dengue where platelet transfusion is the only option for severe depletion, caripill is a worth trying drug. Totally chemical free, I do recommend its usage and have found it to be useful. It defenitely reduced the need for platelet transfusions in some but not in all., to me, it is a worth trying drug but make sure you take it only after your doctor suggests it.Yes Micro Labs has introduced Caripill which is tablet containing leaf extract of papaya (Carica Papaya Leaf extract). It is available in market and many doctors are prescribing & have found it to be useful. However, it is advised to be taken after discussing with your doctor. One should know when to start taking Caripill (ie at what level of platelet count) and doctors are best to judge. You can contact Micro Labs @ +919845855122 by sending a message with your details and a request to call back. Caripill Cell will call back with more information.


Established in 1973, Micro Labs Limited is a multi-faceted healthcare organization with a proficient marketing team, state-of-the-art manufacturing facilities and R&D centres that are at par with international standards. All this, robustly backed by a strong distribution network and path-breaking research work has placed us amongst India’s fast growing transnational healthcare organizations.
In  Indian Pharmaceutical Market, Micro labs is ranked 15th among prescriptions (as per SMSRC Jul’15) and 19th in sales (as per AWACS MAT Sep’ 15).The brand portfolio of Micro Labs includes some of the topmost brands in various specialties like Cardiology, Diabetology, Anti-infectives, Ophthalmology, Pain, etc. Amidst our proud achievers is Dolo, an award-winning brand highly prescribed for fever management.Micro Labs is poised to achieve unparalleled status in the global pharmaceutical industry. Backed by a profound and resolute vision, we now have our eyes set on attaining the $1 billion mark by 2017.

Other accomplishments include:

  • Brand Dolo won ‘Best Managed Brand Award’ awarded by the Institute of Pharmaceutical Healthcare Management & Research’s conference in 2010
  • Dolo 650 was awarded as ‘Brand of the Year 2013’ at 6th Annual Pharmaceutical Leadership Summit 2013
  • Dolo 650 also won the Brand of the Year 2014 GOLD award and Amlong won Brand of the Year 2014 BRONZE Award at AWACS Marketing Excellence Awards 2014
  • Dilip Surana has been been honoured time and again with prestigious awards such as the ‘Dynamic Entrepreneur of the year 2010’, honoured as the Great Son of Karnataka’ by Governor of Karnataka his Excellency HR Bhardwaj in 2011
  • Dilip Surana has been bestowed with the title of ‘Most Dynamic Entrepreneur of the Year’ at 4th Annual India Leadership Conclave and Indian Affairs Business Leadership Awards 2013. He was also honoured as‘Entrepreneur of the Year 2014’ in the following year.
  • Micro Labs has also introduced a lot many number of formulations for the 1st time in the country like Anxit, Dolo-650,Silybon,Ebast and Caripill
  • Various manufacturing facilities of Micro Labs have bagged Quality Excellence awards consistently year after year

Milestones:

  • 19 specialty divisions,with a wide product range and a dedicated field force of 4500 plus.
  • 14 World class manufacturing facilities approved by various agencies including US FDA, UK-MHRA, MCC-South Africa, Health Canada, WHO, TGA Australia & Medsafe-New Zealand, with 2000 qualified technical personnel
  • A vibrant presence in over 40 countries, exporting formulations in all major therapeutic segments
  • Three R&D centres with more than 250 experienced scientists
  • GDA foundation runs the Surana College and Surana PG centre in Bangalore and “Smt. Pyaribai Chunnilalji Surana Charitable trust runs Shree Parshwa Susheel Dham”, a magnificent Jain temple in Attibele, Bangalore

The company is also at the forefront in social contribution, striving to be a model corporate citizen in terms of Social Initiatives with significant contributions in the areas of education and health.

Pharma Leaders Super Brand Award & Recognition to Top Hair Transplant & Cosmetic Plastic Surgeon Dr. Viral Desai

Pharma Leaders Super Brand Award & Recognition to Top Hair Transplant & Cosmetic Plastic Surgeon Dr. Viral Desai

 Eminent Hair Transplant & Cosmetic Plastic Surgeon voted by Network 7 Media Group Jury as “India’s Most Promising Hair Transplant Surgeon 2015” & “India’s most Admired Plastic & Cosmetic Surgeon 2015”

Noted Hair Transplant Surgeon who has been in news for bringing revolutionary treatment process in Hair Transplant & Cosmetic Plastic Surgery received the prestigious & coveted Award & Certificate of Excellence in two important categories such as “India’s Most Promising Hair Transplant Surgeon 2015” & “India’s most Admired Plastic & Cosmetic Surgeon 2015” from the hands of India’s top Music Composer & a living legend Louiz Banks with the presence of Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders, a leading media title in healthcare journalism.  Speaking to the media on receiving the recognition at the top healthcare platform, Dr. Viral Desai Aesthetic & Cosmetic Plastic, Laser, Reconstructive Surgeon & Medical Director at  DHI India, Medical Director – CPLSS said “It indeed is a great privilege and honor to be receiving the award where the top healthcare leaders of the country are present & this award reflects our efforts in the field of Hair Transplant Surgery & Cosmetic Plastic Surgery. Dr Viral Desai received the award at the platform where more than 300 healthcare leaders of the country were present in Mumbai on 30th December 2015. The ace Hair Transplant surgeon also presented a talk on “Patients First in Healthcare : the challenge of creating a new and improved Medicare”. The panel discussion on Will Innovations in India drive the next generation of global cosmetics Dermatology trends ? was acrtively participated by Dr Desai with top skincare leaders of the country such as Dr Manoj Khanna,Plastic Surgeon, Dr. Sumita Shankar, Plastic, Cosmetic & Wound Surgeon, Dr Nilyini G, Cosmetic Dermatologist, Founder, Blu Skin Cosmetology, Dr. Rashmi Shetty,Non-Surgical Aesthetic Medicine Expert , Dr. Poorva Shah,Cosmetic Dermatologist, Ms. Kiren Shrivastav, CEO & Founder, Molecule Communications.


About Dr. Viral Desai

Aesthetic & Cosmetic Plastic, Laser, Reconstructive Surgeon
Medical Director – DHI India, Medical Director – CPLSS

He always saw himself becoming a best surgeon. Even as a child growing up in Mumbai, India, Dr. Viral Desai always dreamt of becoming a doctor. He grew up in a family of doctors – all specialists in their respective fields. His father, Dr. Ramesh Desai, was a Radiologist and Sonologist; Dr. Sarla Desai, his mother, is a Gynaecologist and Obstetrician.

Dr. Desai charted his dream and graduated from medical school (MBBS) from L.T.M.M. College, Sion. He then joined residency in General Surgery and Oncosurgery at Tata Hospital, KEM Hospital and Cooper Hospital. Soon thereafter, he took up the Super-Speciality in Plastic Surgery (M.S.) course at Sir J. J. Group of Hospitals, Mumbai, for the sheer gratification of beautifying lives through aesthetic surgery and “promptly visible results” offered by plastic surgery.

With a desire to be on par with the world’s best, Dr. Desai completed a fellowship in Advanced Cosmetic and Aesthetic Surgery and Laser Training at Singapore with Dr. Woffles Wu – a teaching faculty with the International Aesthetic Surgery Society and the inventor of the Stealth Incision for breast implant. Dr. Wu is renowned for refining various surgical procedures such as liposuction, chin implants, nose jobs, lip sculpting and eyelid surgeries and has invented over ten cosmetic surgery procedures. Dr. Desai took up a fellowship in the Cosmetic Surgery Department at Singapore General Hospital, where he worked with nine cosmetic surgeons and gained from their vast experience.
While working with Dr. Wu, Dr. Desai has fine-tuned the art of various surgical procedures such as Liposculpting, Breast Implants, Eyelid Surgeries, Nose Jobs, Chin Implants, etc. Dr. Viral Desai is today an advanced BOTOX and Fillers user and trainer in India, and has the distinction of performing the maximum number of Botox and Fillers procedures over the latest few years. He also is the pioneer of Non-Surgical Facelift (WAPTOS), Threadlift (APTOS) in India. Dr. Desai has conducted various training workshops in Advanced Botox and Fillers for doctors and has been a faculty for lectures at various medical and non-medical fraternity gatherings.

Dr. Desai is known for communicating with his patients to understand their real needs. “I talk to them at length to get a grasp of what they want”. He likes to screen his patients for “realistic expectations”, and is being prompt to tell patients if their expectations are unrealistic. He believes in giving his patients accurate and complete information of the procedures. Dr. Desai developed his sense of aesthetic surgery as a natural extension of his interest in art and drawing – having done Elementary and Intermediate courses in Art. Most important in a plastic surgeon, he feels, are “common sense and a good artistic inclination”.Dr. Desai is the Medical Director of CPLSS Mumbai and the founder, promoter and Medical Director of DHI in India. All DHI doctors in India are trained and certified by Dr. Desai. He is also the Director of Sarla Hospital and ICU and of Desai Hospitals Pvt. Ltd. In recognition of his achievements in the field of plastic and cosmetic surgery, Dr. Desai was awarded the Icon of Plastic and Cosmetic Surgery in India Award in 2010 at the national level.

Dr. Desai is a board-certified surgeon, M.Ch. (Masters Super-speciality Degree) and D.N.B. (Diplomate of National Board) in Cosmetic and Plastic Surgery. These are the highest level of education degrees in the medical field. The D.N.B. qualification is recognized across all Commonwealth nations.

Dr. Desai is member of International Society of Aesthetic Plastic Surgery (ISAPS), Association of Plastic Surgeons of India (APSI), Indian Association of Aesthetic Plastic Surgeons (IAAPS), CSI, Maharashtra Association of Plastic Surgeons, Consultants Association of India, Indian Medical Association (IMA), Santacruz Medical Association, General Practitioners Association and other associations.

About Pharma Leaders Super Brand Awards


Pharmaleaders Power Brand Awards are the most prestigious annual industry awards, recognized annually that acknowledge and honor individuals and organizations for their remarkable accomplishments. These set of awards are widely acclaimed in the industry circle as   fitting tribute to those individuals and companies that have gone the extra mile to advance the excellence in healthcare through best practices, initiatives,dynamism,drive & towering  leadership. Pharmaleaders Business Leadership Awards are the premier largest business and technology leadership awards program in the sub continent , covering the set of prestigious awards spanning from biotech to Healthcare to CEO awards. Pharma Leaders Power Brand Awards are conferred to those Companies & Individuals who exhibit rare display of innovation for Outstanding Academic & Professional Leadership to individuals & Companies. This top recognition symbolizes the best out of best from chosen few.

Over the last one decade, since the institutionalization of recognizing excellence in healthcare & pharmaceutical business in the form of Pharmaleaders Business Leadership Awards , Pharmaleaders,  has recognized successful individuals and organizations that have empowered the healthcare industry in the global map by creating values & manufacturing prowess. These Pharmaleaders and organizations inspire the public by motivating others to carry out their calls to action, by serving as a champion for their cause and by demonstrating a clear record of accomplishment in addressing urgent, relevant and complex healthcare needs , problems & solutions. They also maintain consistent, long-lasting relationships with the people and communities in which they work. They are truly trendsetters. Thus the Annual Pharmaceutical Leadership Summit &Pharmaleaders Business Leadership Awards conducted years after years, are truly India’s only dedicated celebration of excellence in healthcare innovation, pharmaceutical & medical excellence and brand transformation. Most eagerly awaited annual affair in india, these set of awards reflect benchmark of credibility, leadership spirit & regarded by the industry experts as “Pharmaleaders Power Brands & now Super Brands.

 

 

 

 

 

Noted Plastic & Cosmetic Surgeon Dr. Viral Desai to address on “Patients First in Healthcare : the challenge of creating a new and improved Medicare”

Award Winning Plastic & Cosmetic Surgeon Dr. Viral Desai is al set to floor the delegates at the Asia’s most awaited healthcare Summit, the Pharma Leaders 2015 Summit which is debating on Brand India Winning theme. Dr Desai will be throwing lights on the state of affairs of the Indian healthcare system.

Widely perceived by the industry Leaders, Healthcare Professionals, Policy Makers, Pharma Leaders 2015 edition too will have a significant brand thrust in view of india’s rising power as a top destination for quality manufacturing, research & generic drugs. Announcing the 8th edition of Pharmaleaders Summit & Awards, Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders said ” Pharma Leaders 2015 theme will deliberate on Brand India & its winning spirit as a global power, growing at a growth rate of 13 to 14th % per Annum, the Pharmaceutical Market in India is ranked 3rd in terms of volume and 10th in  terms of market value & clearly the industry is showing the signs for a bigger space in the world market. The issue within India however has complex issues as the key to any reforms & growth are attributed to a strong internal healthcare focus which has many challenges. Healthcare Insurance, access, reach & affordability remain key challenges in india due to a lack of a universal healthcare policies where the patients should be the real beneficiary in any system said Satya Brahma in the news release.

The health system in India today is a mishmash of successes and failures.
The successes

  • India has successfully gone polio free;
  • The forecast for the health care industry in India is very bullish. The industry has been growing at 12% and is expected to be around US 240 Billion by 2020. This means an average compounded annual growth rate of over 20%.  The key drivers will for foreign investment, medical tourism, demographics, economic growth and GoI promotional policies like tax holidays & investment in tertiary care institutions.

The challenges

  • Urban India is showing rapid increase in lifestyle diseases like cardiovascular complaints, diabetes and cancer.
  • Rural India is seeing a sharp increase in non-communicable life style diseases like Respiratory Tract Infections.
  • Poor in urban and rural India are faced with communicable diseases like tuberculosis, Sexually Transmitted Diseases (including HIV/AIDS), dysentery and typhoid.
  • Access to health services is severely limited as health infrastructure proves to be grossly inadequate. This is especially acute in the rural areas where secondary and tertiary care is available with great difficulty.

My views on healthcare reforms

  • Realignment of approach to public health – move away from top-down programmes to respond to demands of the people;
  • Independent monitoring of performance of the Public Health System;
  • Increased investment in secondary and tertiary care, especially in rural &peri-urban areas;
  • Stronger laws to identify and deal with unlicensed practitionersthat wreak havoc in absence of a decent health care system;
  • Open out the medical insurance sector – make it easily available and affordable; extend group insurance policies for the poor (this has started in some States) and also make the sector accountable for its practices and policies.

Dr. Viral Desai is among India’s leading plastic and cosmetic surgeons. He is a qualified M.S., M.Ch, and DNB, and has successfully transformed the lives of his patients for nearly a decade and a half. He is the founder and Medical Director of DHI India, the world’s best technique for hair restoration. He is assisted by a team of super-specialist doctors. CPLSS is among the most premium clinics in India in terms of surgical technique, facilities and in-clinic experience. It is the preferred clinic of celebrities from across the fields of glamour, business, sports and politics. Every field needs role models and so does medicine. A doctor can become a role model usually by publishing in renowned journals, becoming an expert in a specific area, to or by teaching peers at medical conferences. Dr. Viral Desai has achieved all these milestones at a relatively young age. With an excellent academic background, Dr. Viral Desai started his career at a time when there were many misconceptions surrounding plastic surgery. With each passing day, Dr. Desai strove to educate his patients about the intricacies of cosmetic surgery and demonstrate his expertise of the craft at the operating table. Today, after about 15 glorious years of practice, Dr. Viral Desai stands out as the doctor who is most trusted by celebrities and the common man alike for his dedication to the case of his trade and for the excellent results that he continues to deliver in the field of plastic and cosmetic surgery.His dedication and determination to apply himself to the cause of his calling makes Dr. Viral Desai a role model not only to his own team of doctors, but also to doctors and medical students across India.

While working with Dr. Wu, Dr. Desai has fine-tuned the art of various surgical procedures such as Liposculpting, Breast Implants, Eyelid Surgeries, Nose Jobs, Chin Implants, etc. Dr. Viral Desai is today an advanced BOTOX and Fillers user and trainer in India, and has the distinction of performing the maximum number of Botox and Fillers procedures over the latest few years. He also is the pioneer of Non-Surgical Facelift (WAPTOS), Threadlift (APTOS) in India. Dr. Desai has conducted various training workshops in Advanced Botox and Fillers for doctors and has been a faculty for lectures at various medical and non-medical fraternity gatherings.

Dr. Desai is known for communicating with his patients to understand their real needs. “I talk to them at length to get a grasp of what they want”. He likes to screen his patients for “realistic expectations”, and is being prompt to tell patients if their expectations are unrealistic. He believes in giving his patients accurate and complete information of the procedures. Dr. Desai developed his sense of aesthetic surgery as a natural extension of his interest in art and drawing – having done Elementary and Intermediate courses in Art. Most important in a plastic surgeon, he feels, are “common sense and a good artistic inclination”.Dr. Desai is the Medical Director of CPLSS Mumbai and the founder, promoter and Medical Director of DHI in India. All DHI doctors in India are trained and certified by Dr. Desai. He is also the Director of Sarla Hospital and ICU and of Desai Hospitals Pvt. Ltd. In recognition of his achievements in the field of plastic and cosmetic surgery, Dr. Desai was awarded the Icon of Plastic and Cosmetic Surgery in India Award in 2010 at the national level.

 

In India, an estimated 20-40 percent of maternal deaths in India are due to anaemia.Pharma Leaders Brand India Winning to focus on the issue

In India, an estimated 20-40 percent of maternal deaths in India are due to anemia.Globally, anaemia affects 1.62 billion people, which corresponds to 24.8% of the population. The highest prevalence is in preschool-age children (47.4%), and the lowest prevalence is in men (12.7%). However, the population group with the greatest number of individuals affected is pregnant women (41.8%) [3]. In women, anaemia may become the underlying cause of maternal mortality and perinatal mortality [4]. Nearly 50 per cent of women of reproductive age and 26 per cent of men in the age group of 15-59 years are anaemic. South Asia has some of the highest rates of anemia worldwide. At 72 percent, women in the Eastern region of India have a significantly higher prevalence of anemia than the Western states, which estimates 45 percent affected.In addition, a large number of Indian women suffer from anemia throughout the entirety of their lives. The deficiencies can start with low birth weight infant females and worsen during adolescence with the onset of menstruation. Pregnancy further worsens and taxes an already anemic body. Although a plethora of epidemiologic studies have been conducted on anemia in India, National Family Health Surveys and District Level Household and Facility Surveys have proven most useful in tracking the rate of anemia nationally.

Women and children from Eastern India are statistically shown to have higher risk factors for developing anemia. Social class, residence, age, and marital status all play indirect roles in anemia’s prevalence.

Not surprisingly, high socioeconomic status lowered the risk of anemia in all demographics. Education, exposure to mass media, and consumption of milk, milk products, fruits and fish were other protective factors.Statistics also show that low-income urban women and adolescent married women had the highest chances of being anemic.In practical terms, low-income households suffer due to a lack of available resources, such as access to high-quality foods or medicines.

 

Culturally, there is also an inherent attitude towards providing for the males in the family first. This leads to girls and women being given leftovers or food less nutritional in value, especially if resources are limited in a family or community.According to the World Health Organization (WHO), if the community prevalence of anemia is greater than 40 percent, it is considered a high magnitude issue. Although both international and national development campaigns have sought to decrease the anemia burden in India, the real issue is the nutritional status of women throughout their lifespan.

The correlation of anemia and other nutritional deficiencies in this case seems extremely high. My mother—despite being educated as a dietician, from a higher socio-economic class, and someone who consumed a lot of milk and milk products until recently—has been anemic for most of her life. She was a little over a 100 pounds when she gave birth to a healthy, female baby, though she had to make a conscious effort to boost her appetite during her pregnancy. She has spent the majority of her adult life in the United States and not in India, and has remained anemic, on and off, despite how well she eats and maintains her body. It seems to be a childhood deficit that she has not been able to overcome despite her concerted efforts.Indian women in India are at a much greater risk for anemia, women everywhere are likely to be impacted by anemia throughout their lives.It is important to realize that proper nutrition is a life-long process, not a fad diet or one pill fix-all.From statistics, studies, and personal experiences with anemia, it seems clear that the overall nutritional status needs to be enhanced from the beginning of the life cycle.For example, in the current model, an anemic mother gives birth to an underweight female infant, who then becomes anemic as she grows up, and the beginning of menstruation further exacerbates the deficiency. That same anemic woman then goes through pregnancy, which further causes stress, and may lead to another infant who is anemic.It would be easier to narrow the focus of preventative measures to provide proper pre-natal care to pregnant women or to enhance the nutritional resources available to infants, as these are vital developmental stages. Maintaining an overall standard of nutrition, however, is more important and sizably more difficult throughout all stages of life.

 

Pharma Leaders 2015 Edition to debate on “Brand India Winning”

Pharma Leaders 2015 Edition to debate on  “Brand India Winning”

World Healthcare Leaders set to redefine Healthcare Reforms at 8th Annual Pharmaceutical Leadership Summit &Pharmaleaders Business Leadership Awards 2015

The healthcare industry is in the midst of a turbulent global transformation. Healthcare reform policy &  fiscal restraint are some of the biggest challenges  on the minds of politicians, the media and business leaders around the world. The stage is set for a larger consolidation of the pharma sector in india valued at approx 93,000 Crore (INR)  market with a significant presence &  impact in the world. It is evident that the healthcare costs around the world are increasing. In 2013, the total global healthcare spend was $7.2 trillion, or about 11 percent of the world’s gross domestic product. This figure is set to climb more than 5 percent a year for the next few years. In the U.S., costs are expected to rise to $4.8 trillion by 2021& in india however, the situation is complex as india is yet to make landslide healthcare reforms. Prime Minister Narendra Modi, who swept to power at elections last year in May, promised in his poll manifesto to introduce an ambitious universal health care plan that assures free drugs and insurance for serious ailments. But the plan, pegged initially at $26 billion over the next four years and envisioned to be fully operational by 2019, has been pushed back because of budget constraints. Busy with political arithmetic’s, the plan may take a back stage making the cost of the healthcare spending by the poor a toll as 70% of the expenses are still going from the pockets of the common man making life much miserable. To add to the woes are the challenges of the drug companies who are facing the heat of the regulators as ncreasing number of Indian pharmaceutical firms have come under the knife of US Food and Drug Administration (FDA) due to lack of trained staff and cleanliness at their manufacturing units. Against the backdrop of the above summary, Pharmaleaders, Asia’s most analytical news media in healthcare communication is hosting its 8th edition in Mumbai on Wednesday, the 30th December 2015 under the theme “Brand India Winning “at the 8th Annual Pharmaceutical Leadership Summit & Pharma Leaders Business Leadership Awards 2015.

Widely perceived by the industry Leaders, Healthcare Professionals, Policy Makers, Pharma Leaders 2015 edition too will have a significant brand thrust in view of india’s rising power as a top destination for quality manufacturing, research & generic drugs. Announcing the 8th edition of Pharmaleaders Summit & Awards, Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders said ” Pharma Leaders 2015 theme will deliberate on Brand India & its winning spirit as a global power, growing at a growth rate of 13 to 14th % per Annum, the Pharmaceutical Market in India is ranked 3rd in terms of volume and 10th in terms of market value & clearly the industry is showing the signs for a bigger space in the world market. The issue within India however has complex issues as the key to any reforms & growth are attributed to a strong internal healthcare focus which has many challenges. Healthcare Insurance, access, reach & affordability remain key challenges in india due to a lack of a universal healthcare policies where the patients should be the real beneficiary in any system said Satya Brahma in the news release.

Pharmaleaders ( www.pharmaleaders.tv) , a division of Network 7 Media Group ( www.network7mediagroup.net) in association with several trade & industry associations will be focusing on some of the burning issues  confronted by the industry including the much talked about regulatory hurdles & pricing. Top Industry Leaders, Medical practitioners & Policy Makers will be debating in panel discussions to find the reasons of policy paralysis & the way forward. More than 300 leaders from the healthcare industry are expected to attend the 2015 Pharma Leaders Annual Summit including delegations from overseas companies & scientists mostly from Europe.

The much awaited Pharma Leaders Annual Awards will be presented to the top & successful companies & leaders by an eminent panel of Jury Members from the Network 7 Media Group Panel in as many as 40 categories. Pharma Leaders Awards Grand Jury is comprised of a panel of international industry experts,  representing the top creative minds in the field of healthcare, pharma academia, policy formation & the representatives from the  government. Pharma Leaders Awards are credible & independent & enjoy the tag of excellence in innovations in healthcare practice that aim to recognize the remarkable achievement of the companies & Leaders. The 2015 Awards will have significant thrust on initiatives, innovations & insight said the news release.


For Registration, Please contact

Dreamz Integrated Marketing & Communications

Unit No.47, 2nd Floor, Aditya Industrial Estate,

Behind Evershine Mall,Devrukhkar Wadi,Chincholi Bunder Road, Malad (W),Mumbai–400064.

Phone-1 : + 91 22 42481276

Mr Anish Khan : ++ 91 9819499475

anish@dreamzimc.com

Ms Anuja : ++ 91 9920686239

anuja@dreamzimc.com

 

 

 

 

Kiran Shaw at Pharma Leaders awards

I am pleased to note that Pharmaleaders Magazine, India’s first opinion based & research driven bi-monthly magazine which has been relentlessly reporting in Pharma Journalism in a unbiased, fearless & independent way & voicing the opinion of the healthcare industry like us to the statutory Authorities like Ministry of Health & Family Affairs, Dept of Chemicals & Fertilizers, DCGA, FDA & many other institutions to present the pressing demands of the healthcare industry. Pharmaleaders Magazine has also presented our healthcare industry to the global platforms being the largest research based & technologically innovative hub of Healthcare Companies. Pharmaleaders Magazine since last one decade has been organizing world-class “Pharmaceutical Leadership Summit & Excellence Awards” year after year to create a platform for knowledge sharing & dissemination of innovative ideas from the stalwarts of the Industry.

It is heartening to note that Pharmaleaders in association with Pharmexcil & with several leading pharmaceutical trade bodies, industry organizations with the support from Ministry of Commerce, Government of India, is debating on a aptly theme “Brand India : Beyond Generics, Leading with Resilience: Coming Back from Challenge and Heading Towards Super-power Status in Mumbai today I am also given to learn that Pharmaleaders Group which has so far honored, recognized & felicitated more than top 500 performers both Companies & Individuals since 1999 & Pharmaceutical Leadership Business Leadership Awards are most credible & independent, free from interference. The three tier judging mechanism allows each nominee to undergo a public scrutiny first by the SMS, Email & than the eminent Juries .
I thank the Organisers, Jury Members, Mr Satya Brahma, the Chairman of the Summit & the people at large which included Pharma Companies, Pharma Academia, Research Scholars, Biotech Companies & Doctors for choosing me as Global Indian Of The Year 2012. I also congratulate Dr B R Shetty of NMC for getting the Award in Male category. My Congratultations to all the Award Winners & wish them very best in the years to come.

Sarathy Geotech and Engineering Services & Dr. C. R Parthasarathy awarded at 6th Annual India Leadership Conclave & Business Leadership Awards 2015

Sarathy Geotech and Engineering Services & Dr. C. R Parthasarathy awarded at 6th Annual India Leadership Conclave & Business Leadership Awards 2015

India’s Fastest Growing Company in Geotechnical Engineering 2015 to the firm Sarathy Geotech and Engineering Services & Entrepreneur of the Year 2015 to the Founder CMD Dr.C.R Parthasarathy

Monday, 21st September 2015, Mumbai, Maharashtra, India. Sarathy Geotech and Engineering Services Pvt. Ltd., (SGES), founded by Dr. C R Parthasarathy, providing  geotechnical engineering services for both the offshore and onshore industries received the rare distinction at ILC Power Brand Awards 2015 organised by Network 7 Media Group as Sarathy Geotech and Engineering Service led by its visionary Chairman Dr. CR Parthasarathy received twin awards one for the company & the other for steering the company to its greater heights. India’s Fastest Growing Company in Geotechnical Engineering 2015 went to the firm Sarathy Geotech and Engineering Services while  Dr. CR Parthasarathy received the Entrepreneur of the Year 2015.

The much awaited leadership conclave, the 6th Annual India Leadership Conclave 2015 witnessed the presence of top Business Leaders, Politicians, Social Activists, Women Leaders, Movie Stars & Rebel Leaders in a star-studded powerful gatherings at Hotel Sahara Star, Mumbai, India assembled to debate at title theme India @ 68 & received the prestigious Leaders. Among those who spoke at the conclave are veteran Healthcare Expert Dr. Mukesh Batra, Satya Brahma, Chairman of Network 7 Media Group, noted Cartoonist Aseem Trivedi, Datamatics Chairman Dr. Lalit Kanodia, Aam Aadmi Partry Leader Mayank Gandhi. More than 300 power packed leaders from the various spectrums of the society gathered in a single platform. The glittering award ceremony saw the presence of Celebrities such as Govinda with wife Sunita Ahuja, Sanjay Khan, Zarine Khan, Ayesha Shroff who had gathered to see the award ceremony where Tina Ahuja, Govinda’s daughter was voted as Emerging Actress of the Year while Ayesha & Jackie Shroff’s son Tiger Shroff received the Promising Actor award at the 6th Annual India Leadership Conclave & Awards 2015. Farah Ali Khan received the prestigious Innovative Leadership in Luxury Brands Concept 2015 while South Actress & Mass queen Ragini Dwivedi  received the Promising Actress Award.

Satya Brahma, Chairman, India Leadership Conclave, Dr. Mukesh Batra, Chairman Dr. Batras & Bollywood Star Govinda conferred the awards in more than 40 categories.Commenting on the awards, Satya Brahma said The Award conferred to Sarathy Geotech & Engineering Services & its Founder Dr. C. R. Parthasarathy signifies the remarkable achievement of the group company & undoubtedly has achieved success & achievements as a reliable companion of construction, infrastructure, oil & gas companies, the visionary leadership of Dr. C. R Parthasarathy played a significant role in building the enviable position that it has earned today”, added Satya. Dr. C. R Parthasarathy while accepting the award said “This Award bears testimony of our efficient services to our clients & clearly motivates all of us to undertake future projects with a great sense of responsibilities.

I am very happy and overwhelmed with this honor. It was an humbling experience to receive the award on the stage in front of a vibrant audience, who are amazing personalities and excelled in their own field and the media as well. I would like to dedicate this award to all my lieutenants/well-wishers who have contributed immensely to the growth of SGES throughout the journey, a difficult one though. I will bring back this energy to all my team members, encourage them to work hard and excel further. This recognition motivates all of us to continue servicing future projects with a great sense of responsibility.Not but the least, for whatever little achievement earned so far, there is a lady behind me, my wife, Mrs Anupama, who co-founded SGES and shared all the gain & pain, involved and supported in every decision making so far. I think the credit also goes to her. We will share together every bit of joy from these awards. Outlining the vision of the company, Dr. Parthasarathy said , we are committed to be the leading player and service provider of choice in the fields of Geo-technique and geo-physics for both offshore and onshore markets, Innovations coming out of our R&D and projects to be leveraged in providing cost effective and safe solutions & Operational excellence that can optimize costs to the customer

The glittering award ceremony saw the presence of Celebrities such as Govinda with wife Sunita Ahuja, Sanjay Khan, Zarine Khan, Ayesha Shroff who had gathered to see the award ceremony where Tina Ahuja, Govinda’s daughter was voted as Emerging Actress of the Year while Ayesha & Jackie Shroff’s son Tiger Shroff received the Promising Actor award at the 6th Annual India Leadership Conclave & Awards 2015. Farah Ali Khan received the prestigious Innovative Leadership in Luxury Brands Concept 2015 while South Actress & Mass queen Ragini Dwivedi  received the Promising Actress Award.

About – Sarathy Geotech and Engineering Services Pvt. Ltd., (SGES)

Sarathy Geotech and Engineering Services Pvt Ltd was established in the year 2007. We have been providing Geo-Technical Engineering Services for

  • Offshore
  • Oil & Gas industry
  • Refineries
  • Infrastructure projects
  • Onland Constructions

We provide Integrated Survey Services for Offshore projects and EPC for Onland Substructure Projects. We have consistently exceeded customer expectations by our solutions. This has been possible by the excellent staff and consultants that have expertise and experience working on several national and international proj- ects that calls for diverse expertise.

VISION STATEMENT

To be a leading player and service provider of choice in the fields of Geo-physics and Geo-technique for both offshore and onshore markets

MISSION STATEMENT

As an innovative Geo-technical and Geo-Physical company, driven by values, we provide top class solutions with value addition to customers that are backed by best practices.

Dr. CR Parthasarathy holds B.E. and M.E. degrees in Civil/Geotechnical Engineering from Bangalore University. He was awarded PhD (Geotechnical) from Indian Institute of Science, Bangalore, India in 2002. He started his career as a Geotechnical Engineer in 1993. He was involved in numerous site investigation/engineering studies at various levels for multistoried complexes, industrial buildings, embankments, bridges, water-retaining structures, subways, pavements, offshore platforms, pipelines, mobile drilling units etc. During 1998 to 2001, while pursuing for doctoral degree, he has involved in several consultancy projects along with his professors (viz., design of pile foundation for grade separator, failure investigation for canal embankments, geotechnical investigation for launching pads, design of soil nailing, etc). Dr. CR Parthasarathy has undertaken pile drivability studies, jack-up rig foundation investigations and design. He was involved in the pile installation monitoring of several offshore platforms, involved in several Jackup rig moves and in addition has served as QA/QC Engineer for several Geotechnical Investigations on dedicated survey vessels, viz., M/V Mariner, M/V Logos Searcher, GTV Samudra Sarvekshak, M/V Bavenit (deep water vessel), Drilling barge Sungei Muthiara, M/V. Diabaz. He has also worked in few projects as QA/QC Engineer for Benthic Geosciences Australia for site investigations utilizing PROD (Portable Remote Operated Drill) in deep waters. His sphere of activities has extended beyond in India to Singapore, Australia, Tunisia, Malaysia, Indonesia, Vietnam, Thailand, Brunei etc.Dr. CR Parthasarathy is the founder director of Sarathy Geotech & Engineering Services Pvt ltd.

………………………………………………………………….

Rated by Experts & widely acclaimed by thought leaders, India Leadership Conclave Annual Affair is just not a leadership forum, it symbolizes the hopes & aspirations of the billion people reflected by the speakers at the forum. “ILC POWER BRANDS” has  been rated in Asia as the most credible & coveted Awards developed by Network 7 Media Group consisting of eminent jury members of the different verticals of the society &  is conferred to the Individuals & Companies in its annual meet at the Indian affairs India Leadership Conclave & Indian Affairs Business Leadership Awards. since the institutionalization of the Business Leadership Awards in 2010, India Leadership Conclave & Indian Affairs Business Leadership Awards has been India’s most awaited & asia’s most respected set of Awards conferred to Companies & Individuals who have made their mark through their remarkable performances despite all odds & has made India Proud!. Since the last five successful years, the platform has recognized, felicitated more than 300 fortune 500 Companies & towering captains & Leaders of the Country

Facial Plastic Surgeon & Healthcare Economist Dr. Debraj Shome to address Healthcare Delivery in India – Vision 2020 at India Leadership Conclave 2015

Facial Plastic Surgeon & Healthcare Economist Dr. Debraj Shome to address Healthcare Delivery in India – Vision 2020  at India Leadership Conclave 2015

India Needs Flexible Healthcare Reforms to boost India’s pride in Global Healthcare Map. Free medicines cannot fix an overburdened public healthcare system in which many hospitals lack up-to-date equipment and doctors. Thus, the free essential drugs scheme is just one of the many steps the government will need to take to ensure universal healthcare. I feel the adoption at the national level of an e-healthcare system like the one followed in Tamil Nadu can help to provide free medicines to those who need them in a transparent and efficient manner.

India is a fertile ground for entrepreneurs, given its large pool of world-class talent and resources. India’s ability to generate wealth and create social good will come if we let entrepreneurs flourish by encouraging and enabling innovation. Innovation and biotechnology can transform our numerous challenges – healthcare, education, development, agriculture, environment, and energy among others – into opportunities by developing innovative products that can benefit millions and drive economic growth.

However, unlike in the West where capital markets are willing to invest in innovation for a long term, innovation in India is viewed as high-risk, low gain option and hence not investor-friendly. Investors in India are not prepared to invest in capital intensive long-term innovation based business models. India, therefore, needs a robust innovation “ecosystem.” The government needs to establish strong industry-academia linkages to foster the spirit of enterprise and drive employment. However, a national innovation ecosystem is not enough, because if innovation is to flourish, ideas have to be funded to bring them to the market. As a traditionally risk-averse nation, India has rarely been at the forefront of innovation. Indian companies have mostly imitated others and became very good at it. Even in the biotech sector, most companies operate in the low-risk services and generic diagnostics, vaccines and therapeutics space.

It is time for biotechnology companies, especially in India and other developing countries, to re-orient their efforts to aggressively harness innovation through partnerships and collaborations to attain the dream of ensuring healthcare for all. The government also needs to be an enabler by putting in place policies that will create a robust innovation “ecosystem” in India. Today, the Indian government has abdicated its responsibility to provide basic healthcare to its people, but it’s holding a gun at the pharma industry and asking it to shoulder the burden. The industry has worked very hard to create a cost-effective and competitive sector. It is actually producing the cheapest drugs in the world, but on top of that the government is dictating how much profit the pharma industry is allowed to make. A complete lack of political will and effective administration have kept accessible and affordable healthcare out of the reach of most Indians.

The lack of a universal healthcare system in our country compels patients to bear almost 80% of the healthcare costs directly from their pocket. The opportunity therefore lies in leveraging India’s value advantage and scientific excellence to come up with innovative technology for offering world-class products at affordable prices, thus making a huge difference to millions of patients in India.

India has a fast-growing economy as well as an ever-expanding, ever-urbanized population, however its healthcare system still has a lot of potential for development. India’s drug industry to touch $48 billion by 2018 Industry may see growth on back of patent expiry of some blockbuster drugs in US and local demand. India’s drugs and pharmaceuticals industry is likely to post total sales of Rs.2.91 trillion ($47.88 billion) by 2018, with an average yearly growth of at least 14%, aided by a rapidly growing domestic market and the newly emerging export opportunity as patents of at least a dozen blockbuster drugs in the US expire in the next three years. “During 2014-2016, about $92 billion worth patented drugs are expected to go off patent in the US as compared with $65 billion during 2010-12, as per the research study by Pharmaleaders.

Pharmaleaders agree that India’s pharmaceutical sector will touch close to US$ 55 billion by 2020 & the Indian pharmaceutical market will be the sixth largest in the world by 2020.The rise of pharmaceutical outsourcing and investments by multinational companies (MNCs), allied with the country’s growing economy, committed health insurance segment and improved healthcare facilities, is expected to drive the market’s growth. India is today one of the top emerging markets in the global pharmaceutical scene. The sector is highly knowledge-based and its steady growth is positively affecting the Indian economy. The organised nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country.From a market size of US$ 12.6 billion in 2009, the Indian pharmaceutical market will grow to US$ 55 billion by 2020, with the potential to reach US$ 70 billion in an aggressive growth scenario. In a pessimistic scenario characterised by regulatory controls and economic slowdown, the market will be depressed but is still expected to reach US$ 35 billion.India currently exports drug intermediates, Active Pharmaceutical Ingredients (APIs), Finished Dosage Formulations (FDFs), Bio-Pharmaceuticals, and Clinical Services across the globe. The exports of pharmaceuticals from India grew to US$ 14.6 billion in 2012-13 from US$ 6.23 billion in 2006-07, registering a compound annual growth rate (CAGR) of around 15.2 per cent.The allowance of foreign direct investment (FDI) in India’s pharma sector has been well received by foreign investors. According to data released by the Department of Industrial Policy and Promotion (DIPP), the drugs and pharmaceutical sector attracted FDI worth Rs 60,100.91 crore (US$ 9.94 billion) between April 2000 and June 2014.

A year ago, newly elected Indian Prime Minister Narendra Modi was promising to do big things, including amend a law that made it unreasonably difficult for companies to acquire land for factories and infrastructure projects. He’s more or less given up on that particular ambition, after stumbling into fierce resistance in the opposition-dominated upper house of Parliament.

The comedown arrives just as GDP growth slowed to 7 percent in the second quarter, disappointing those hoping India would shoot past a faltering China to become the world’s fastest-growing major economy.

Modi needs to change this souring narrative, and fast. Individual states might still be able to push forward much-needed reforms in land and labor. But at the national level, the opposition has succeeded in painting Modi’s agenda as pro-business and anti-poor. That’s a precarious place for the prime minister to be, especially with politically crucial elections coming up in largely agrarian Bihar state.

Part of the problem is that Modi, despite his fabled skill as a communicator, has failed to explain to poorer Indians how reform will benefit them in addition to well-connected tycoons. He might have better luck if he sets aside the most controversial issues for now and focuses instead on sectors — among them, education and health care — that affect the masses more directly.

Radical reform is required in these areas as well. As a 2014 McKinsey report noted, half of public spending on basic services in India never reaches ordinary citizens. While primary and secondary education is free, the quality of public schools is atrocious: Over 90 percent of Indian children are enrolled in primary school, but that number drops to 36 percent by the time kids reach the upper secondary level. Similarly, access to health care is poor. India has only one doctor for every 1,700 people — well below the World Health Organization recommendation of one for every 1,000. At 66 years, India’s life expectancy ranks the country at 139 among 194 nations, lower than nations like Bangladesh and Indonesia.

As McKinsey notes, there’s no dearth of good ideas for how to improve outcomes for students and patients. The focus on providing free public health care has stretched resources too thin. A better strategy, suggested last week by the government’s own think tank, NITI Aayog, would be to shift to an insurance-based system. Citizens would all contribute to a “Sickness Fund” and then be reimbursed for care, regardless of whether they visited a public or private hospital. Modi’s government proposed a similar system for life and accident insurance last year, allowing the poor to access benefits for a nominal premium. The government could provide vouchers to aid the very poorest.

A voucher system would also help schoolchildren. Government schools suffer not just from a lack of funding, but from weak teachers. A World Bank study found that 25 percent of teachers didn’t show up to school and only half were actually teaching classes. Giving parents the freedom to choose schools — whether public or private — would encourage competition and hopefully improve quality at state schools.

Importantly, one of the government’s central successes thus far has been to build the foundations for such reforms, which require transferring cash directly to patients and parents. Over the last year, the government has opened 175 million new accounts for citizens. The Aadhar system of unique identity cards, launched under the previous government, now covers 870 million people. Officials can be reasonably confident that they can target cash vouchers to deserving recipients without money being skimmed off by middlemen. The cost to the government would be far less than trying to revamp the public education and health care systems from scratch.

Even poor Indians have shown they’re willing to pay for private-sector clinics and schools, despite sometimes steep expenses. Rather than fighting this trend, the government should clear away the red tape which prevents new facilities from being built. That would bring costs down, while direct aid would help the poorest afford fees.

These might seem like radical ideas to some in India. That’s the point: Reform doesn’t only mean making life easier for industrialists. Such changes would have an immediate impact on the lives of the poor, even while creating efficiencies throughout the economy. Modi could begin right away by launching pilot programs in states controlled by his Bharatiya Janata Party, which might allow him to post a few quick wins. At this point, he has little to lose.

Healthcare landscape in India has many challenges starting with access to specialist care in rural areas, skewed doctor–patient ratios, long wait times and finally when your turn comes in, very little doctor time available for a consultation compared to other countries worldwide (thanks to busy doctors and scarcity of specialists). And in the middle of these delivery challenges is the alarming increase in non-communicable diseases or NCD’s. It is estimated that roughly 40% of the adult population already has a chronic condition (asthma, diabetes, hypertension, osteoarthritis) or at significant risk of developing the condition due to family history, eating and sedentary habits, pollution and air quality.

Mobile and internet technology that can be applied to healthcare like the cloud services, wearable devices, internet of things (IOT) has offered tremendous opportunities to solve and mitigate some of the challenges impacting healthcare delivery in India.

We can broadly look at four areas where healthcare transformation is happening and that holds more potential for the future – Improve Healthcare Access, Improvements to Care Delivery, Distribution of healthcare service and Health Management tools and technologies. Improve Access: Imagine the impact when every mobile becomes a tele-health device that can make doctor consultations and follow-ups happen from any place. Effective tele-health via mobile opens up more doctor slots (Consultations at home, early mornings or late evenings or even in transit) and make it possible to access specialist doctors from tier-2 and 3 cities and towns. Appointments and follow-throughs are streamlined with appointment slot booking and updates happening real time with information available to doctors and patients.

Care Delivery: Access to diagnostic reports and data digitally improves quality of care and contributes to data collections that can be used for clinical research. For example in the case of post-discharge, Care management supplements doctor notes and inputs – It reduces pressure and time involved for doctors to repeat information and instructions that can be made available through technology with reminders and rich media like exercise videos and diet/nutrition charts.

Distribution: Services delivered from the comfort of home saves time and fixes inefficiencies and mark-ups involved in distribution channels. For example, automation in distribution of medicines from the time of prescription to door delivery will be faster and cheaper.

Health Management: Online communities and support groups for doctors and patients bring together people with similar interests to collaborate and improve quality of care and diagnosis. This offers some of the best hope to manage the risks of chronic and lifestyle conditions.

This transformation is in different stages today depending on your provider – doctor, hospital or the locations you live in. But every major healthcare group to smaller hospitals have started forays in these areas. Apollo Hospitals group has made it possible to access health records online and has launched new generation of tele-medicine services. Care Hospital group is offering a whole host of convenience and efficiencies through their patient portal and mobile. A large charity based hospital like Rangadore Memorial Hospital (RMH) offers Care Management for all mobile users (smart phones as well as via text messages).

The transformation has begun and as we look out there is will more standardization of these services with greater adoption. Technology innovation holds the best chance to impact and solve some of the healthcare challenges we face.